Novo Nordisk A/S

Industry

  • Digital Health
    • Disease Management
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals

Other Names/Subsidiaries

  • BIOCORP
  • Biocorp Production SA
  • Calibrium
  • Carbometrics
  • Cardior Pharmaceuticals
  • Cardior Pharmaceuticals GmbH
  • Catalent
  • Corvidia Therapeutics
  • Dicerna Pharmaceuticals
  • Embark Biotech
  • Emisphere Technologies
  • FORMA Therapeutics
  • Inversago Pharma
  • KabaFusion
  • MB2
  • Neose Technologies
  • Neotope Neuroscience
  • Novo Holdings A/S
  • Novo Nordisk Pharmaceuticals
  • Pharmaero Aps
  • Xellia Pharmaceuticals ApS
  • Ziylo
See more in Biomedtracker

Latest on Novo Nordisk A/S

Scrip

Will They Or Won’t They? Tariff Question Looms For Drugmakers

 
• By Jessica Merrill

Industry anxiety is riding high as pharmaceutical manufacturers wait to hear from US president Donald Trump about whether or not drugs will be included in the next round of tariffs to be announced on

Pink Sheet

Will They Or Won’t They? Tariff Questions Loom For Drugmakers

 
• By Jessica Merrill

Anxiety is high as pharmaceutical manufacturers wait to hear from President Trump about whether or not drugs will be included in the next round of tariffs to be announced on 2 April. Trump is expected

Scrip

Stock Watch: How Tariff Threat Might Boost Pharma Q1

 
• By Andy Smith

Pandemic Anniversary Resonates Within a few days of the fifth anniversary of the declaration of the COVID-19 pandemic by the World Health Organization, the first quarter of 2025 headed towards its clo

Scrip

Novo Scores Cardio Wins But Lilly Still Tipped To Take GLP-1 Crown

 
• By Andrew McConaghie

Novo Nordisk has just presented two successful cardiovascular-focused Phase III studies of semaglutide, but analysts think they will not be enough to stop Eli Lilly’s rival, tirzepatide, from dominati